Proof-of-concept of Switch-DARPin platform established in vivo, enabling the use of logic-gated and reversible immune activators Preclinical safety, efficacy, and pharmacokinetics support MP0621’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback